Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease

Many patients with hematological malignancies, such as acute myeloid leukemia, receive an allogeneic hematopoietic cell transplantation (HCT) to cure their underlying condition. Allogeneic HCT recipients are exposed to various elements during the pre-, peri- and post-transplant period that can disru...

Descripción completa

Detalles Bibliográficos
Autores principales: van Lier, Yannouck F., Vos, Jaël, Blom, Bianca, Hazenberg, Mette D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980553/
https://www.ncbi.nlm.nih.gov/pubmed/36794370
http://dx.doi.org/10.1080/19490976.2023.2178805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980553/
https://www.ncbi.nlm.nih.gov/pubmed/36794370
http://dx.doi.org/10.1080/19490976.2023.2178805

Ejemplares similares